The latest at the Foundation | Access to Medicine Foundation

New 2024 Index Methodology places greater focus on measuring patient reach

10 October 2023

Five ways to ramp up access to essential diabetes products

Spotlight on the generics industry: New analysis looks at access efforts of 5 major companies

26 September 2023

The 2021 AMR Benchmark pinpointed opportunities for companies. Did they take them?

21 November 2023

Resource Center

Explore our research reports and publications

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023

Joint event with World Economic Forum on the evolving role of generics – Meeting Report

Foundation names Expert Review Committee for 2024 Access to Medicine Index

How companies perform on ensuring access to their SRHR-related products for women and girls in LMICs

25 November 2022

GSK in top spot, Johnson & Johnson close second. AstraZeneca leaps up to join the top three. Bayer and Merck climb the Index ranking.

Sickle cell cures are coming. African children can’t be left behind

Poor countries desperately need better access to generic medicines

15 February 2023

Joint roundtable with Chatham House identifies key opportunities for expanding access to medical oxygen

12 December 2022

Achievements so far

Read more about the Foundation's impact

Closing the gaps in access to diabetes care in low- and middle-income countries

Global oxygen suppliers commit to closing oxygen gaps in low- and middle-income countries